ArticleThe Journal of biological chemistry2012

Serum calcium-decreasing factor, caldecrin, inhibits receptor activator of NF-κB ligand (RANKL)-mediated Ca2+ signaling and actin ring formation in mature osteoclasts via suppression of Src signaling pathway.

Mineko Tomomura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.